AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02185391 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Audience Response System
Description: patients use during oral presentations an audience response system
Study NCT02185391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone interview
Description: patients receive motivational telephone interviews after their residence in rehabilitation clinics
Study NCT02865005 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapsone 5.0% Gel (Allergan)
Description: Topical Gel
Study NCT02829762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Program of geriatric and Social intervention associated techniques of Domotic and Remote assistance
Description: Implementation of social aids, a monthly social monitoring and home improvement with domotic techniques and remote assistance
Study NCT04144972 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Medtronic Summit RC+S or Percept RC
Description: The investigators will perform DBS versus sham (randomized) to evaluate efficacy of stimulation for analgesia. Closed-loop DBS will be compared to open-loop DBS in a patient blinded, randomized fashion after initial, efficacy evaluation.
Study NCT00804271 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: memantine
Description: memantine tablets, OD, 12 weeks
Study NCT04144972 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Medtronic Summit RC+S or Percept RC
Description: The investigators will perform DBS versus sham (randomized) to evaluate efficacy of stimulation for analgesia. Closed-loop DBS will be compared to open-loop DBS in a patient blinded, randomized fashion after initial, efficacy evaluation.
Study NCT02827539 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: LessRay
Description: A software device has been developed that combines the benefits of reduced radiation associated with low-dose and/or pulse settings while preserving and possibly offering enhanced resolution. LessRay is a software device that is viewed on a separate monitor next to the fluro screen of the C-arm.
Study NCT02827539 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Standard Fluoroscopy
Description: For control arm, patients will receive the standard fluoroscopy for imaging.
Study NCT01199614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: open-label PTH(1-84)
Description: open label PTH(1-84) at either 25mcg every other day, 25mcg every day, 50mcg daily, 75mcg daily, or 100mcg daily
Study NCT01021384 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Problem Solving Education
Description: Problem Solving Education (PSE) is an evidenced-based empowerment strategy, targeted to mothers of young children to promote family well-being by decreasing the burden of maternal depressive symptoms and maternal parenting stress and improving social functioning.
Study NCT05622903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cash Benefit
Description: Spending from the cards was not restricted to food but could be spent on anything and anywhere Visa was accepted. The debit cards were credited with the first payment on November 18th, 2020 and the second payment on December 18th, 2020. The program continued with monthly credits through August 2021.
Study NCT04475861 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-arginine supplements and nutritional supports
Description: The enrolled subjects will then be randomized into two groups. The subjects will receive either L-arginine (the study group) or another amino acid supplement (the control group), with 60 patients in each group. All the food intake of the subjects during the 4 weeks of the study will be recorded and supervised by responsible dietitians.
Study NCT01054898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: advocacy intervention
Description: A 12-week telephone social support and empowerment intervention consisting of empowerment training, scheduled weekly telephone calls, and 24-hour access to a hotline for abused women
Study NCT01054898 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual community services
Description: standard care for abused women in the community
Study NCT01561664 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle and fat biopsy
Description: muscle and fat biopsy
Study NCT01561664 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: muscle and fat biopsy
Description: muscle and fat biopsy
Study NCT03013465 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Diet
Description: Participants will receive a controlled diet with 0 g/d of broccoli. Meals will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Study NCT03013465 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Base Diet with Broccoli
Description: Participants will receive a controlled diet with 100 g of broccoli at both breakfast and dinner daily. Meals will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Study NCT04240587 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TrueTear™ intranasal neurostimulator (ITN)
Description: The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN active arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN sham arm will receive tips without the current.
Study NCT04240587 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TrueTear™ intranasal neurostimulator (ITN)
Description: The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN active arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN sham arm will receive tips without the current.
Study NCT04059744 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fun-Knee
Description: Portable and low cost sensors are used in the Smart Knee Sleeve. The sensor system is composed of two inclinometers and one Bluetooth transmitter.~Fun Knee™ contains total knee replacement exercises that are gamified and supported on mobile device running on Android or iOS platforms. The mobile apps is able to capture the angle a and position data from the two inclinometers on smart knee sleeve.The free-sized knee sleeve prototypes are purchased and assembled by our collaborating vendor.
Study NCT03674021 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest Pain Choice visual aid
Description: The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain. The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.
Study NCT01480739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg (50 mg x 2) AZD5069
Description: Twice daily for 7 days
Study NCT01480739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg Placebo
Description: Twice daily for 7 days
Study NCT03492593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lycopene
Description: A tomato oleoresin containing lycopene
Study NCT03492593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: beta-carotene
Description: 13C beta-carotene
Study NCT03492593 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: emulsified liquid meal alone
Study NCT05622903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Cash Benefit
Description: No monthly cash benefit.
Study NCT02644434 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Strategy
Description: Jailed wire technique: Both MV and SB are wired. The MV is stented with wire protection in SB. The SB is not further treated unless there is threatened SB closure, severe ostial pinching of SB (>90%), TIMI flow grade decrease in SB, or SB dissection greater than type A. If one of these criteria exists, the SB would be rewired and a kissing balloon inflation is undertaken.~Provisional two-stent strategy: Lesion preparation and MV stenting are the same as the jailed wire technique. Provisional T stenting of the SB could be undertaken if one of the following criteria exists after SB rewiring and a kissing balloon inflation is undertaken: threatened SB closure, severe ostial pinching of SB (>90%), TIMI flow grade decrease in SB, or SB dissection greater than type A.
Study NCT02644434 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intentional strategy
Description: Jailed balloon technique: The technique has been detailed in previous studies. A monorail balloon that is angiographically sized to approximate the Side Branch (SB) vessel diameter is advanced into the SB. If there is TIMI flow grade decrease in the SB after MV stenting, the SB balloon is inflated to simulate attempt to reopen the SB. The procedure would be completed with the standard kissing balloon technique no matter there is SB compromise or not.~Elective two-stent strategy: Patients in this subgroup would undergo crush procedure or any other elective two-stent strategy which stenting SB before MV stenting.
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IT, IV, or SC
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given orally (PO) or IV
Study NCT02318056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aquacel® Ag Burn Glove
Description: burn dressing
Study NCT02318056 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mepilex® Transfer Ag
Description: burn dressing
Study NCT02318056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: antibiotic
Description: antibiotic burn dressing
Study NCT04201743 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acellular amniotic membrane derived allograft injection (NuDYN)
Description: Injectable acellular amniotic membrane derived allograft (NuDYN) through routine follow-up with physical examination, pain, function and quality of life measurements and compare dose effects (1 mL versus 2 mL of NuDYN injection) in the treatment of knee osteoarthritis.
Study NCT03859284 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: flowable resin composite
Description: gold standard
Study NCT03859284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self adhering flowable
Description: moist bonding self adhering flowable composite
Study NCT03859284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self adhering flowable with adhesive
Description: moist bonding self adhering flowable composite with the aid of an adhesive system.
Study NCT01516827 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Description: TF-CBT (see also HThttp://tfcbt.musc.eduTH) is a manualised intervention for traumatized children and adolescents 7 to 16 years old and their parent/caregiver. The primary components are summarized by the acronym PRACTICE: Parenting skills, Psychoeducation, Relaxation, Affect modulation, Cognitive processing, Trauma narrative, In vivo mastery of trauma reminders, Conjoint child-parent session, and Enhancing safety and future development. We will use the manual as provided by Cohen et al. and available in German. The treatment program will comprise 12 sessions with children and parents (partly separated, partly conjoined sessions) of 90 minutes each. The 12 sessions will be distributed over a duration of 16 weeks.
Study NCT01686568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega-3
Description: Patients in this group will receive oral supplementation with EPA+DHA (3.9grams/day) for 6 months.
Study NCT01686568 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin Hydrochloride
Description: Given IV
Study NCT05314673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Intra-lesional Bevacizumab Injection in primary pterygium
Description: The surgical technique featured:~subconjunctival anesthetic (lidocaine 2%) injection 5 mm from limbus; excision of the pterygium, starting from its head, followed by pterygium body removal; exposition of a triangular-shaped bare scleral bed (3-4 mm) conjunctival autograft stitched limbus to limbus with 10/0 vicryl suture Any intraoperative complication was noted and was treated accordingly. All patients received dexamethasone + tobramycin eye drops postoperatively 4 times a day in the 1st week. The eye drops were tapered over 4 weeks.~Patients were examined 30 days before bevacizumab injection (D-30), before surgery (day 0: D0) and then at D7, M1, M3, and M6 after surgery.
Study NCT05314673 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pterygium surgery without adjunctive therapy
Description: The surgical technique featured:~subconjunctival anesthetic (lidocaine 2%) injection 5 mm from limbus; excision of the pterygium, starting from its head, followed by pterygium body removal; exposition of a triangular-shaped bare scleral bed (3-4 mm) conjunctival autograft stitched limbus to limbus with 10/0 vicryl suture
Study NCT03862027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal Balloon catheter
Description: Pressures \[Esophageal Pressure (Pes), Airway Pressure (Paw), and Transpulmonary Pressure (Ptp)\] are measured directly through the ventilator. The waveforms of Paw, Pes, and Ptp will be visualized on the ventilator. Ptp is obtained from Paw - Pes. All patients will have baseline measurements recorded of ICP, CPP, and MAP.~PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O (Optimal PEEP).~Measurements of Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and mean arterial pressure (MAP) will be repeated 5 minutes after the change in PEEP.
Study NCT01190930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin Calcium
Description: Given PO
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mercaptopurine
Description: Given PO
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Given IT, PO, or IV
Study NCT02560805 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microneurography
Description: Skin will be stimulated with a pencil-shaped electrode to find a certain nerve. Once the nerve is found, two tiny sterile wire needles (about the size of acupuncture needles) will be put in the skin. One needle is put just under the skin at a short distance away from the nerve, and the other one into the nerve. The needles are attached to a computer recorder to record the nerve activity. It may take up to one hour to get the needles in the right place. After the tiny needle is in the right place, investigators record nerve activity at rest for about 10 minutes. Then, it will be recorded throughout the rest of the visit (up to 4 hours).
Study NCT01523080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Extended release Gel tabs 650 mg
Study NCT01523080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Extended release Gel tabs 650 mg
Study NCT01190930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegaspargase
Description: Given IV
Study NCT01190930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT03424161 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Secret RF
Description: Subjects will receive treatment with the Secret RF device
Study NCT01190930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05569135 — intervention group
Intervention type: DEVICE
Intervention: Laser ablation
Description: A diode-laser that has been reported to be safe and effective in several treatments including pilonidal disease, anal fistula, hemorrhoids, and vascular ablation was used to obtain shrinkage of pilonidal cyst
Study NCT02909868 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BackBeat-PHC
Description: A conductance catheter will be used to obtain PV loops prior to a Moderato pacemaker implant procedure.
Study NCT00541983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: XOMA 052
Description: Subjects in six successive dose groups will receive a single IV infusion (mg/kg) of study drug on Day 0. The total time of the infusion will be 1 hour ± 15 minutes.
Study NCT00541983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects in six successive dose groups will receive a single IV infusion (mg/kg) of study drug on Day 0. The total time of the infusion will be 1 hour ± 15 minutes.
Study NCT02002143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Appointments
Description: Participants randomly assigned to the intervention group will participate in GAs of 8 patients for 1.5 hours, every 3 months for 2 years. The 3-member Care Team (MD, nurse, behaviorist) will attend each session. The nurse facilitates the session and curriculum. The MD responds to specific health questions. Patients may schedule time before or after to review their clinical results with the MD/nurse (e.g. HbAIC).~Key elements include 1) completed pre-appt questionnaires used to identify a patient's educational needs; 2) patients use goal setting and action plans to initiate and maintain healthy behaviors; 3) each class has a designated purpose and learning objectives; 4) sessional feedback, which is used to adapt the next class (3 months later) based on patient needs.
Study NCT02002143 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individual Appointments (IAs)
Description: Participants randomly assigned to the IAs group will receive eight traditional 1-to-1 appointments, seeing their physician quarterly as per standard care in BC. They will be referred to ancillary services such as nutrition advice, counseling, and physical activity promotion according to 'usual care' practice. In addition, we will organize 4 1-hour social events for these participants annually. The 4 social events will be 1) a potluck lunch; 2) a movie night; 3) an event chosen by participants; and 4) a talent show. From our experience, these events enhance compliance to reporting and minimize dropouts. These events also serve to minimize 'socialization bias' that may otherwise potentially influence health measures including quality of life.
Study NCT03184844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: thalidomide:50mg/d p.o at bedtime
Study NCT01561287 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dermal Autograft
Description: Patients in the dermal autograft group will undergo harvest of a dermal autograft from the lower abdomen at the time of mastectomy, which will be used to cover the lower pole of the tissue expander.
Study NCT01561287 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: AlloDerm
Description: The acellular dermal matrix used in our study is AlloDerm (LifeCell Corp., Branchburg, N.J.) The AlloDerm group will consist of patients without a suitable abdomen for autografting and those who declined the dermal autograft procedure. Patients in the dermal allograft group will have placement of AlloDerm over the lower pole of the tissue expander. Patients with a lower abdominal scar and sufficient abdominal laxity for autograft harvest will be offered this technique.
Study NCT03614936 — intervention group
Intervention type: OTHER
Intervention: Geriatric Screening Test G8
Description: Geriatric screening test (Oncodage-G8). The oncologist realizes it and proposes the oncological treatment which seems to him then the most adapted (treatment which can be different from that proposed after the oncological evaluation only).
Study NCT03614936 — intervention group
Intervention type: OTHER
Intervention: Geriatric fragility test GERICO
Description: GERICO geriatric frailty test (if possible the same day as the G8 and in any case in the same week): Realized by the oncologist, it includes:~* the socio-cultural evaluation scale,~* the ADL autonomy questionnaire,~* assessment of locomotor disorders,~* nutritional assessment,~* the MMSE Cognitive Function Evaluation Questionnaire,~* the GDS-4 mood rating scale,~* the comorbidity assessment test (Charlson Index)
Study NCT03813030 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of lidocaine
Description: Lidocaine is intravenously administered in clearance visit and blood samples are taken to calculate individual clearance of each participant.
Study NCT03813030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 2.5% and Prilocaine 2.5% cream, USP (2.5% lidocaine, 2.5% prilocaine, Actavis Pharma incorporated, USA)
Description: Topical application in dermal-sampling visit
Study NCT03813030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocorit 2%-Ampullen (Gebro Pharma Gesellschaft mit beschränkter Haftung, Austria)
Description: Intravenous infusion in clearance visit